MedPath

Study on Fatty Liver Disease comparing the intervention with Cauterization and Blood letting therapy

Phase 2
Completed
Conditions
Health Condition 1: K759- Inflammatory liver disease, unspecified
Registration Number
CTRI/2023/11/059678
Lead Sponsor
Dr Megha R
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

Sonologically diagnosed case of grade 1 and grade 2 fatty liver disease

Exclusion Criteria

Uncontrolled DM and HTN, suffering with other systemic disorders

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in ultra sonography reading and SGOT, SGPT level, Weight, reduce in Klama, Adhmana, agnimandya and hritkanta daha after 15 days of completion of 4th sitting of the procedureTimepoint: At baseline, 1st week, 2nd week, 3rd week, 4th week and 6th week
Secondary Outcome Measures
NameTimeMethod
Objective criterias like USG, SGOT SGOT, WeightTimepoint: At base line & After 15 days of completion of treatment i.e., on 6 weeks
© Copyright 2025. All Rights Reserved by MedPath